XPhyto Therapeutics (CSE: XPHY- OTCQB: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive to provide an update on what the company is planning for a very busy 2021. Rogers laying out the plan for three areas of their business.
Rogers telling Proactive they expect major steps forward in their Diagnostic, Drug Formulation, and Psychedelics divisions.